Powered by LiquidBiopsy, ClearID provides a minimally-invasive tool to monitor cancer patients, enabling more frequent testing and real-time molecular profiling of tumor DNA. Leveraging patented cell enrichment technology, the test analyzes patients' individual mutations to match them with targeted cancer therapies and clinical trials.
Nous utilisons des cookies pour les recommandations de contenu, la mesure du trafic et les publicités personnalisées. En utilisant ce site Web, vous acceptez la et la .